ASHLEY HEPNER: Open Payments
NPI 1871894329 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 26 payments from 10 companies in 2025. Trend: 2023 $31 · 2024 $4,408 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $100 |
| Madrigal Pharmaceuticals | 4 | $96 |
| ABBVIE INC. | 5 | $89 |
| QOL Medical, LLC | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $36 |
| Gilead Sciences, Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $21 |
| Boston Scientific Corporation | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: XIFAXAN, REZDIFFRA, Sucraid, MAVYRET, ENTYVIO, Wegovy, CREON, OMVOH.
Industry payments across OH — which companies pay providers there.
